Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy
- 1 March 1999
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 43 (4), 735-743
- https://doi.org/10.1016/s0360-3016(98)00475-1
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Population-based study of long-term survival in patients with clinically localised prostate cancerThe Lancet, 1997
- Assessment of quality of life after radical radiotherapy for prostate cancerBritish Journal of Urology, 1996
- Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.Journal of Clinical Oncology, 1996
- Quality of Life: Radical Prostatectomy Versus Radiation Therapy for Prostate CancerJournal of Urology, 1995
- National Patterns of Prostate Cancer Treatment by Radical Prostatectomy: Results of a Survey by the American College of Surgeons Commission on CancerJournal of Urology, 1994
- Recent results of management of palpable clinically localized prostate cancerCancer, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Quality of life and psychosocial status in stage D prostate cancerQuality of Life Research, 1992
- Toxicity, Physical Function and Everyday Activity Reported by Patients with Inoperable Non-Small Cell Lung Cancer in a Randomized Trial (Chemotherapy Versus Radiotherapy)Acta Oncologica, 1988
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987